Literature DB >> 8758104

Tuberculosis in sub-Saharan Africa: a regional assessment of the impact of the human immunodeficiency virus and National Tuberculosis Control Program quality.

M F Cantwell1, N J Binkin.   

Abstract

BACKGROUND: The effect of the human immunodeficiency virus (HIV) epidemic on tuberculosis (TB) has been evaluated for certain countries in sub-Saharan Africa. However, no multi-country comparisons have been performed of the magnitude of the changes in TB case rates and the roles of the HIV epidemic and national TB control program (NTP) quality in these changes.
METHODS: We examined trends in TB case rates after 1985 for 20 sub-Saharan African countries, and also from 1975-1984 for 10 of these countries (core countries). Average annual changes in TB case rates after 1985 were stratified by 1992 urban low-risk HIV seroprevalence and by NTP quality, as determined by a survey of international TB experts.
RESULTS: Case rates in the core countries decreased by an average of -1.6% per year prior to 1985, but increased by an average of +7.0% per year after 1985 (+7.7% per year after 1985 in all 20 countries). Average annual case rates after 1985 increased approximately twice as fast in countries with high vs low or intermediate HIV seroprevalence ratings. In both the core countries and all 20 countries, the average annual rate of rise in case rates after 1985 decreased as NTP quality rating increased. This relationship persisted even after stratification by HIV seroprevalence rating.
CONCLUSIONS: TB case rates have increased in sub-Saharan Africa since 1985. These increases were relatively greater as HIV seroprevalence increased, and relatively lower as NTP quality increased. Improving NTP quality is essential to mitigate the resurgence of TB in the HIV era.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Comparative Studies; Cross-cultural Comparisons; Developing Countries; Diseases; Epidemics; Health Services Evaluation; Hiv Infections--prevention and control; Incidence; Infections; Measurement; Organization And Administration; Prevalence; Program Evaluation; Programs; Quality Of Health Care; Research Methodology; Research Report; Studies; Tuberculosis--prevention and control; Viral Diseases

Mesh:

Year:  1996        PMID: 8758104     DOI: 10.1016/s0962-8479(96)90004-0

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  9 in total

1.  Recommendations for screening and prevention of tuberculosis in patients with HIV and for screening for HIV in patients with tuberculosis and their contacts.

Authors:  Richard Long; Stan Houston; Earl Hershfield
Journal:  CMAJ       Date:  2003-10-14       Impact factor: 8.262

2.  Tuberculosis and the HIV epidemic: increasing annual risk of tuberculous infection in Kenya, 1986-1996.

Authors:  J A Odhiambo; M W Borgdorff; F M Kiambih; D K Kibuga; D O Kwamanga; L Ng'ang'a; R Agwanda; N A Kalisvaart; O Misljenovic; N J Nagelkerke; M Bosman
Journal:  Am J Public Health       Date:  1999-07       Impact factor: 9.308

3.  Antibodies against Mycobacterial proteins as biomarkers for HIV-associated smear-negative tuberculosis.

Authors:  Michael Siev; Douglas Wilson; Supreet Kainth; Victoria O Kasprowicz; Catherine M Feintuch; Elizabeth R Jenny-Avital; Jacqueline M Achkar
Journal:  Clin Vaccine Immunol       Date:  2014-03-26

Review 4.  An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa.

Authors:  A D Harries; D Maher; P Nunn
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

5.  The burden and characteristics of tuberculosis/human immunodeficiency virus (TB/HIV) in South Korea: a study from a population database and a survey.

Authors:  Chang-Hoon Lee; Ji-Young Hwang; Dae-Kyu Oh; Mee-Kyung Kee; Eunjung Oh; Jung-Wook An; Jinhyun Kim; Heonsook Do; Hee-Jin Kim; Sung Soon Kim; Hwahyun Kim; Jeong-Gu Nam
Journal:  BMC Infect Dis       Date:  2010-03-12       Impact factor: 3.090

6.  The economic burden to families of HIV and HIV/tuberculosis coinfection in a subsidized HIV treatment program.

Authors:  Wilson E Sadoh; Osa Oviawe
Journal:  J Natl Med Assoc       Date:  2007-06       Impact factor: 1.798

Review 7.  To control and beyond: moving towards eliminating the global tuberculosis threat.

Authors:  Timothy F Brewer; S Jody Heymann
Journal:  J Epidemiol Community Health       Date:  2004-10       Impact factor: 3.710

8.  M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.

Authors:  Gibson S Kibiki; Bert Mulder; Wil M V Dolmans; Jessica L de Beer; Martin Boeree; Noel Sam; Dick van Soolingen; Christophe Sola; Adri G M van der Zanden
Journal:  BMC Microbiol       Date:  2007-05-31       Impact factor: 3.605

9.  Bovine tuberculosis and brucellosis in traditionally managed livestock in selected districts of southern province of zambia.

Authors:  J B Muma; M Syakalima; M Munyeme; V C Zulu; M Simuunza; M Kurata
Journal:  Vet Med Int       Date:  2013-06-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.